3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
23
Neoplasm Metastasis
11
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
5
Neoplasms
3
Brain Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Pancreatic Neoplasms
2
Glioblastoma
2
Urogenital Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Squamous Cell
1
Metastatic Castration-Resistant Prostate Cancer
1
Melanoma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Hormone Receptor Positive Breast Cancer
1
Head and Neck Neoplasms
1
Glioma
1
Ependymoma
1
Interventions
Tamoxifen
9
Letrozole
5
Anastrozole
5
Radiotherapy
3
Radiation
3
Neoadjuvant Therapy
3
afimoxifene
2
Trastuzumab
2
Surgical Procedures, Operative
2
Simvastatin
2
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Mastectomy, Segmental
2
Lapatinib
2
Gene Expression Profiling
2
trastuzumab biosimilar HLX02
1
telapristone acetate
1
sargramostim
1
polyphenon E
1
pasireotide
1
palbociclib
1
oxybutynin
1
liposomal doxorubicin
1
exemestane
1
Zoledronic Acid
1
UAB 30
1
Tea
1
Sugars
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Intraductal, Noninfiltrating
×
abemaciclib
×
Clear all
No trials found.